NovoCure Limited Comprehensive Income
NovoCure Limited (NVCR) reported Comprehensive Income of -$14.19 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-07-23
- NovoCure Limited comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$14.19M.
- NovoCure Limited comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$72.59M.
- NovoCure Limited comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$22.13M.
- NovoCure Limited comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$37.97M.
- NovoCure Limited comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$168.66M.
- NovoCure Limited comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$210.08M.
- NovoCure Limited comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$91.80M.
- NovoCure Limited comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$57.69M, a 407.78% decline from fiscal 2020.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$14.19M 10-Q · filed 2026-07-23 | -$86.78M 10-Q · filed 2026-07-23 | -$108.91M derived: sum of 3 quarters · filed 2026-07-23 | -$146.88M derived: sum of 4 quarters · filed 2026-07-23 | |
| 2026-03-31 | -$72.59M 10-Q · filed 2026-04-30 | -$94.73M derived: sum of 2 quarters · filed 2026-07-23 | -$132.69M derived: sum of 3 quarters · filed 2026-07-23 | -$173.74M derived: sum of 4 quarters · filed 2026-07-23 | |
| 2025-12-31 | -$22.13M derived: 10-Q 12 month − 10-Q 9 month · filed 2026-07-23 | -$60.10M derived: sum of 2 quarters · filed 2026-07-23 | -$101.15M derived: sum of 3 quarters · filed 2026-07-23 | -$134.17M 10-Q · filed 2026-07-23 | |
| 2025-09-30 | -$37.97M 10-Q · filed 2025-10-30 | -$79.01M derived: sum of 2 quarters · filed 2026-07-23 | -$112.03M 10-Q · filed 2025-10-30 | -$178.08M derived: sum of 4 quarters · filed 2026-07-23 | |
| 2025-06-30 | -$41.05M 10-Q · filed 2026-07-23 | -$74.07M 10-Q · filed 2026-07-23 | -$140.11M derived: sum of 3 quarters · filed 2026-07-23 | -$172.54M derived: sum of 4 quarters · filed 2026-07-23 | |
| 2025-03-31 | -$33.02M 10-Q · filed 2026-04-30 | -$99.06M derived: sum of 2 quarters · filed 2026-04-30 | -$131.50M derived: sum of 3 quarters · filed 2026-04-30 | -$164.24M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | -$66.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$98.48M derived: sum of 2 quarters · filed 2026-02-26 | -$131.22M derived: sum of 3 quarters · filed 2026-02-26 | -$168.66M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$32.43M 10-Q · filed 2025-10-30 | -$65.18M derived: sum of 2 quarters · filed 2025-10-30 | -$102.61M 10-Q · filed 2025-10-30 | -$153.17M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$32.74M 10-Q · filed 2025-07-24 | -$70.18M 10-Q · filed 2025-07-24 | -$120.74M derived: sum of 3 quarters · filed 2026-02-26 | -$170.23M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$37.44M 10-Q · filed 2025-04-24 | -$87.99M derived: sum of 2 quarters · filed 2026-02-26 | -$137.49M derived: sum of 3 quarters · filed 2026-02-26 | -$194.20M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$50.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$100.05M derived: sum of 2 quarters · filed 2026-02-26 | -$156.76M derived: sum of 3 quarters · filed 2026-02-26 | -$210.08M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$49.50M 10-Q · filed 2024-10-30 | -$106.20M derived: sum of 2 quarters · filed 2024-10-30 | -$159.52M 10-Q · filed 2024-10-30 | -$196.95M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | -$56.71M 10-Q · filed 2024-07-25 | -$110.03M 10-Q · filed 2024-07-25 | -$147.46M derived: sum of 3 quarters · filed 2025-02-27 | -$174.24M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | -$53.32M 10-Q · filed 2024-05-02 | -$90.75M derived: sum of 2 quarters · filed 2025-02-27 | -$117.54M derived: sum of 3 quarters · filed 2025-02-27 | -$142.31M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | -$37.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$64.22M derived: sum of 2 quarters · filed 2025-02-27 | -$88.99M derived: sum of 3 quarters · filed 2025-02-27 | -$91.80M 10-K · filed 2025-02-27 | |
| 2022-09-30 | -$26.79M 10-Q · filed 2023-10-26 | -$51.56M derived: sum of 2 quarters · filed 2023-10-26 | -$54.37M 10-Q · filed 2023-10-26 | -$83.09M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-06-30 | -$24.77M 10-Q · filed 2023-07-27 | -$27.58M 10-Q · filed 2023-07-27 | -$56.31M derived: sum of 3 quarters · filed 2024-02-22 | -$69.21M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-03-31 | -$2.81M 10-Q · filed 2023-05-04 | -$31.53M derived: sum of 2 quarters · filed 2024-02-22 | -$44.44M derived: sum of 3 quarters · filed 2024-02-22 | -$58.25M derived: sum of 4 quarters · filed 2024-02-22 | |
| 2021-12-31 | -$28.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$41.63M derived: sum of 2 quarters · filed 2024-02-22 | -$55.44M derived: sum of 3 quarters · filed 2024-02-22 | -$57.69M 10-K · filed 2024-02-22 | |
| 2021-09-30 | -$12.90M 10-Q · filed 2022-10-27 | -$26.72M derived: sum of 2 quarters · filed 2022-10-27 | -$28.96M 10-Q · filed 2022-10-27 | -$24.64M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | -$13.81M 10-Q · filed 2022-07-28 | -$16.06M 10-Q · filed 2022-07-28 | -$11.73M derived: sum of 3 quarters · filed 2023-02-23 | -$2.15M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | -$2.24M 10-Q · filed 2022-04-28 | $2.08M derived: sum of 2 quarters · filed 2023-02-23 | $11.66M derived: sum of 3 quarters · filed 2023-02-23 | $13.41M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $4.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $13.90M derived: sum of 2 quarters · filed 2023-02-23 | $15.65M derived: sum of 3 quarters · filed 2023-02-23 | $18.74M 10-K · filed 2023-02-23 | |
| 2020-09-30 | $9.58M 10-Q · filed 2021-10-28 | $11.33M derived: sum of 2 quarters · filed 2021-10-28 | $14.42M 10-Q · filed 2021-10-28 | $18.56M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | $1.75M 10-Q · filed 2021-07-29 | $4.84M 10-Q · filed 2021-07-29 | $8.98M derived: sum of 3 quarters · filed 2022-02-24 | $10.62M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | $3.09M 10-Q · filed 2021-04-29 | $7.22M derived: sum of 2 quarters · filed 2022-02-24 | $8.87M derived: sum of 3 quarters · filed 2022-02-24 | $6.99M derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | $4.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $5.78M derived: sum of 2 quarters · filed 2022-02-24 | $3.90M derived: sum of 3 quarters · filed 2022-02-24 | -$8.60M 10-K · filed 2022-02-24 | |
| 2019-09-30 | $1.65M 10-Q · filed 2020-10-29 | -$239.00K derived: sum of 2 quarters · filed 2020-10-29 | -$12.73M 10-Q · filed 2020-10-29 | -$28.64M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | -$1.89M 10-Q/A · filed 2020-10-02 | -$14.38M 10-Q/A · filed 2020-10-02 | -$30.28M derived: sum of 3 quarters · filed 2021-02-25 | -$41.83M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | -$12.49M 10-Q/A · filed 2020-10-02 | -$28.40M derived: sum of 2 quarters · filed 2021-02-25 | -$39.95M derived: sum of 3 quarters · filed 2021-02-25 | -$55.40M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | -$15.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$27.45M derived: sum of 2 quarters · filed 2021-02-25 | -$42.91M derived: sum of 3 quarters · filed 2021-02-25 | -$63.62M 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$11.55M 10-Q · filed 2019-10-31 | -$27.00M derived: sum of 2 quarters · filed 2019-10-31 | -$47.71M 10-Q · filed 2019-10-31 | -$58.54M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | -$15.46M 10-Q · filed 2019-07-25 | -$36.16M 10-Q · filed 2019-07-25 | -$46.99M derived: sum of 3 quarters · filed 2020-02-27 | -$58.21M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | -$20.71M 10-Q · filed 2019-05-02 | -$31.54M derived: sum of 2 quarters · filed 2020-02-27 | -$42.76M derived: sum of 3 quarters · filed 2020-02-27 | -$63.75M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | -$10.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$22.05M derived: sum of 2 quarters · filed 2020-02-27 | -$43.04M derived: sum of 3 quarters · filed 2020-02-27 | -$61.12M 10-K · filed 2020-02-27 | |
| 2017-09-30 | -$11.22M 10-Q · filed 2018-10-25 | -$32.21M derived: sum of 2 quarters · filed 2018-10-25 | -$50.30M 10-Q · filed 2018-10-25 | -$72.26M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-06-30 | -$20.99M 10-Q · filed 2018-07-26 | -$39.08M 10-Q · filed 2018-07-26 | -$61.04M derived: sum of 3 quarters · filed 2019-02-28 | -$95.07M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-03-31 | -$18.08M 10-Q · filed 2018-04-26 | -$40.05M derived: sum of 2 quarters · filed 2019-02-28 | -$74.08M derived: sum of 3 quarters · filed 2019-02-28 | -$114.40M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2016-12-31 | -$21.97M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$55.99M derived: sum of 2 quarters · filed 2019-02-28 | -$96.32M derived: sum of 3 quarters · filed 2019-02-28 | -$132.22M 10-K · filed 2019-02-28 | |
| 2016-09-30 | -$34.03M 10-Q · filed 2017-10-26 | -$74.35M derived: sum of 2 quarters · filed 2017-10-26 | -$110.26M 10-Q · filed 2017-10-26 | -$144.69M derived: sum of 4 quarters · filed 2018-02-22 | |
| 2016-06-30 | -$40.32M 10-Q · filed 2017-07-27 | -$76.23M 10-Q · filed 2017-07-27 | -$110.66M derived: sum of 3 quarters · filed 2018-02-22 | -$136.68M derived: sum of 4 quarters · filed 2018-02-22 | |
| 2016-03-31 | -$35.91M 10-Q · filed 2017-04-27 | -$70.34M derived: sum of 2 quarters · filed 2018-02-22 | -$96.36M derived: sum of 3 quarters · filed 2018-02-22 | -$125.72M derived: sum of 4 quarters · filed 2018-02-22 | |
| 2015-12-31 | -$34.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$60.46M derived: sum of 2 quarters · filed 2018-02-22 | -$89.81M derived: sum of 3 quarters · filed 2018-02-22 | -$113.09M 10-K · filed 2018-02-22 | |
| 2015-09-30 | -$26.02M 10-Q · filed 2016-11-02 | -$23.27M 10-Q · filed 2016-05-10 | -$55.38M derived: sum of 2 quarters · filed 2016-11-02 | -$78.65M 10-Q · filed 2016-11-02 | |
| 2015-06-30 | -$29.36M 10-Q · filed 2016-07-28 | -$52.63M 10-Q · filed 2016-07-28 | |||
| 2014-12-31 | -$80.68M 10-K · filed 2017-02-23 | ||||
| 2013-12-31 | -$77.37M 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |